Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of neoplasms with CCI-779/EKB-569 combination

Treatment of neoplasms with CCI-779/EKB-569 combination

US Patent RE40418 · Granted Jul 1, 2008

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antineoplastic combinations with mTOR inhibitor, trastuzumab and/or HKI-2722020
Method for treating gefitinib resistant cancer2020
Method for treating gefitinib resistant cancer2020
Anti-tumor activity of CCI-779 in papillary renal cell cancer2014
Protein tyrosine kinase enzyme inhibitors2011
Use of CCI-779 as an antineoplastic agent2010
Method of potentiating chemotherapy and treating solid tumors2008
Protein tyrosine kinase enzyme inhibitors2008
Use of CCI-779 as an antineoplastic agent2007
Reversal of multidrug resistance in human colon carcinoma cells2005
Antineoplastic combinations comprising2003
Antineoplastic combinations comprising2003